as on November 5, 2025 at 8:01 pm IST
Day's Low
Day's High
6.87%
Downside
-1.43%
Upside
52 Week's Low
52 Week's High
14.16%
Downside
61.80%
Upside
Check Biocryst Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
0.32
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-12.23
Industry PE ratio
-2.8140502793296087
PEG Ratio
-0.28
EBITDA
58.5M
Revenue (TTM)
557.5M
Profit Margin
-6.41%
Return On Equity TTM
-1925.37%
Track how Biocryst Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Biocryst Pharmaceuticals Inc in the last 5 years
Lowest (-186.63x)
June 30, 2025
Today (-12.23x)
November 5, 2025
Industry (-2.81x)
November 5, 2025
Highest (-4.77x)
December 31, 2020
Today’s Price to Earnings Ratio: -12.23x
Compare market cap, revenue, PE, and other key metrics of Biocryst Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | 59.62% | -12.23 | -6.41% | |
| BUY | $18.8B | NA | 16.59 | 40.65% | |
| BUY | $41.8B | NA | 21.32 | 13.81% | |
| BUY | $14.2B | 42.73% | 33.88 | 15.95% | |
| BUY | $64.0B | -27.17% | 24.89 | 27.83% |
The Biocryst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biocryst Pharmaceuticals Inc investment value today
Current value as on today
₹1,04,500
Returns
₹4,500
(+4.5%)
Returns from Biocryst Pharmaceuticals Inc Stock
Dollar Returns*
₹5,351 (+5.35%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Biocryst Pharmaceuticals Inc. Average target price of $20.27
Get share price movements and forecasts by analysts on Biocryst Pharmaceuticals Inc.
What analysts predicted
65.52%UPSIDE
Target Price
$20.27
Current Price
$6.99
Analyzed by
18 Analysts
Target
$20.27
Biocryst Pharmaceuticals Inc target price $20.27, a slight upside of 65.52% compared to current price of $6.99. According to 18 analysts rating.
Search interest for Biocryst Pharmaceuticals Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -26.79M → 12.89M (in $), with an average increase of 27998.1% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 17.5% return, outperforming this stock by 63.2%
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 17.8% return, outperforming this stock by 22.0%
Price Dip
![]()
In the last 6 months, BCRX stock has moved down by -38.7%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 163.35M → 159.39M (in $), with an average decrease of 2.4% per quarter
| Organisation | Biocryst Pharmaceuticals Inc |
| Headquarters | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
| Industry | Health Technology |
| CEO | Mr. Jon P. Stonehouse |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Clayton Fletcher | Chief Business Development Officer |
Mr. Charles K. Gayer | President & Chief Commercial Officer |
Ms. Alane P. Barnes | Senior VP, Chief Legal Officer & Corporate Secretary |
Mr. Babar Ghias | CFO & Head of Corporate Development |
Dr. Yarlagadda S. Babu Ph.D. | Chief Discovery Officer |
Ms. Jinky Ang Rosselli | Chief Data & Insights Officer |
Mr. Philip George | Chief Strategy Officer |
Mr. Jon P. Stonehouse | CEO & Executive Director |
Ms. Stephanie Angelini | Chief People Officer & Chief Communications Officer |
Dr. William P. Sheridan MBBS | Chief Development Officer |
Biocryst Pharmaceuticals Inc share price today is $6.99 as on . Biocryst Pharmaceuticals Inc share today touched a day high of $6.89 and a low of $6.51.
Biocryst Pharmaceuticals Inc share touched a 52 week high of $11.31 on and a 52 week low of $6 on . Biocryst Pharmaceuticals Inc stock price today i.e. is trending at $6.99,which is 38.20% down from its 52 week high and 16.50% up from its 52 week low.
Biocryst Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Biocryst Pharmaceuticals Inc (BCRX) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Biocryst Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biocryst Pharmaceuticals Inc share’s latest price of $6.99 as on November 5, 2025 at 8:01 pm IST, you will get 1.4306 shares of Biocryst Pharmaceuticals Inc. Learn more about
fractional shares .
Biocryst Pharmaceuticals Inc stock has given 59.62% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?